Aurinia Pharmaceuticals AUPH Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Aurinia Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 6:06 AM EST
- Fiscal year
- FY2025
- Accession
- 0001600620-26-000017
| --- | --- | --- | | ASSETS | | | | Other current liabilities | 2,480 | 1,531 | | Total current liabilities | 93,724 | 97,763 | | Finance lease liabilities, less current portion | 52,322 | 58,554 | | Deferred revenue, less current portion | 12,648 | 1,699 | | Deferred compensation and other noncurrent liabilities | 6,662 | 9,408 | | Operating lease liabilities, less current portion | 4,900 | 5,743 | | Total liabilities | 170,256 | 173,167 | | Commitments and contingencies (Note 5) | | |
Item 16. Form 10-K Summary.
FAQ
- What is Aurinia Pharmaceuticals's contract liabilities?
- Aurinia Pharmaceuticals (AUPH) reported contract liabilities of $12.65M in Q4 2025.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.
Ask your AI about Aurinia Pharmaceuticals's contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
